Status:
COMPLETED
The Effect of Pectoral Blocks on Perioperative Pain in Gender Affirmation Top Surgery
Lead Sponsor:
University of California, San Francisco
Conditions:
Gender Dysphoria
Opioid Use
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Despite recent advancements with regional and local anesthesia, postoperative pain continues to be a major concern for patients undergoing breast surgery. Opioids, often in combination with NSAIDS and...
Detailed Description
All participants will be seen in clinic with the attending surgeon anywhere from two weeks to a few months prior to the date of surgery. Participants will also have a pre-op visit with anesthesia a fe...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) class I-III
- Ages 18-65
- Undergoing gender confirmation breast reduction surgery by a single surgeon at a single center
Exclusion
- Previous breast surgeries
- Current breast cancer or history of treatment for breast cancer
- Current chronic pain syndromes
- Coagulopathy
- Allergy to local anesthetics
- Infection at the injection site
Key Trial Info
Start Date :
June 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04474366
Start Date
June 16 2020
End Date
April 30 2022
Last Update
July 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143